Quoin Pharmaceuticals
QNRX
1 hedge funds and large institutions have $184K invested in Quoin Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
47% less capital invested
Capital invested by funds: $345K → $184K (-$161K)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$76K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $177K | – | – | – |
|
2
UBS Group
Zurich,
Switzerland
| $5K | – | – | – |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $2K | – | – | – |
|
|
4
Jane Street
New York
| – | -$76K | – | – |
|
QNRX Hedge Fund Activity: Q4 2016 in Review
1 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q4 2016, worth a combined $184K — down 47% from $345K a quarter earlier.
Fund positioning in QNRX was balanced in Q4 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was Jane Street, cutting an estimated $76K.
- 1 institutional investor held Quoin Pharmaceuticals (QNRX) as of Q4 2016, unchanged from Q3 2016.
- Funds reported $184K of Quoin Pharmaceuticals stock for Q4 2016, down 47% quarter-over-quarter.
- 0 funds opened new Quoin Pharmaceuticals positions in Q4 2016 and 0 closed out.
- The largest Quoin Pharmaceuticals seller in Q4 2016 was Jane Street, an estimated $76K sold.
Based on aggregated 13F filings for Q4 2016.